Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Return on Assets (ROA)
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Boston Scientific Corp., ROA, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions


The net income (loss) of the company demonstrates significant volatility over the observed period. Initial data in 2005 show a positive net income of $628 million, which then sharply declines to substantial losses in 2006 and 2008, with values reaching as low as -$3,577 million and -$4,068 million respectively. This is followed by a mixture of losses and gains, including recovery phases such as in 2010, 2011, 2016, 2018, and notably a strong peak in 2019 at $4,700 million. However, profits see another dip in 2020, plummeting to a slight loss before recovering again to positive values in 2021 and 2022.

Total assets exhibit a mostly declining trend from 2006 through 2012, dropping from $31,096 million to $17,154 million, reflecting potential divestitures or impairments. From 2012 onwards, there is a pronounced upward trajectory in total assets, rising steadily from around $17 billion to over $32 billion by the end of 2022, indicating asset growth possibly due to acquisitions, capital investments, or improved asset management.

Return on assets (ROA) reflects the volatility seen in net income, with several years of negative returns coinciding with losses, particularly marked declines in 2006 (-11.5%) and 2012 (-23.71%). Positive ROA figures appear intermittently, with a notable improvement from 2017 onwards, peaking at 15.38% in 2019, which aligns with the peak in net income. The sharp fluctuations in ROA highlight periods of operational difficulty interspersed with phases of financial recovery.

In synthesis, the financial data indicate cyclical challenges impacting profitability, offset by phases of recovery and growth. Asset levels experienced a downturn in the late 2000s to early 2010s, followed by substantial growth thereafter. The correlation between net income and ROA underscores the company’s variable efficiency in asset utilization over the years, with recent trends suggesting a positive trajectory in financial health and operational returns.


Comparison to Competitors

Boston Scientific Corp., ROA, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Boston Scientific Corp., ROA, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)